Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Oct;72(4):865–868. doi: 10.1038/bjc.1995.425

Effect of endogenous and exogenous EGF on the growth of EGF receptor-hyperproducing human squamous cell carcinoma implanted in nude mice.

Y Kitagawa 1, M Ueda 1, N Ando 1, S Ozawa 1, M Kitajima 1
PMCID: PMC2034045  PMID: 7547232

Abstract

The effect of epidermal growth factor (EGF) on the biological behaviour of human tumours in vivo is still controversial. We investigated the effect of EGF on the growth of an EGF receptor-hyperproducing human epidermoid carcinoma, A431 tumour, and on a human small-cell lung carcinoma, H69 tumour, without detectable EGF receptor by using sialoadenectomised (sialex) mice as an endogenous EGF-suppressed animal model. The plasma EGF concentration in the sialex athymic mice was significantly lower than that in the sham-operated mice (P < 0.05). After exogenous EGF replacement with an implanted minipump, the plasma EGF concentration was significantly increased in both groups (P < 0.05). There was no significant difference between the body weight growth curves of sialex and sham-operated mice with and without EGF treatment. The tumour weight of A431, both estimated and measured in sialex mice, was significantly lower than that in sham-operated control mice (P < 0.05), and the growth of A431 tumour was significantly increased by exogenous EGF treatment (P < 0.05). Mitotic activity of these tumours detected by immunohistochemical staining for incorporated bromodeoxyuridine indicated a mitosis-stimulatory effect of endogenous and exogenous EGF on A431 tumours. In contrast to these findings on A431 tumours, a growth-stimulatory effect of endogenous and exogenous EGF was not observed in the H69 tumour. These results suggest a growth-promoting effect of physiological levels of endogenous EGF on EGF receptor-hyperproducing human tumours in vivo.

Full text

PDF
865

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amagase H., Tamura K., Okuhira M., Kakimoto M., Amano H., Hashimoto K., Fuwa T., Tsukagoshi S. Epidermal growth factor prolongs survival time of tumor-bearing mice. Jpn J Cancer Res. 1990 May;81(5):495–500. doi: 10.1111/j.1349-7006.1990.tb02597.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Carpenter G., Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216. doi: 10.1146/annurev.bi.48.070179.001205. [DOI] [PubMed] [Google Scholar]
  3. Das M. Epidermal growth factor: mechanisms of action. Int Rev Cytol. 1982;78:233–256. doi: 10.1016/s0074-7696(08)60107-2. [DOI] [PubMed] [Google Scholar]
  4. Fidler I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res. 1990 Oct 1;50(19):6130–6138. [PubMed] [Google Scholar]
  5. Fox C. F., Linsley P. S., Wrann M. Receptor remodeling and regulation in the action of epidermal growth factor. Fed Proc. 1982 Nov;41(13):2988–2995. [PubMed] [Google Scholar]
  6. Gill G. N., Lazar C. S. Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells. Nature. 1981 Sep 24;293(5830):305–307. doi: 10.1038/293305a0. [DOI] [PubMed] [Google Scholar]
  7. Ginsburg E., Vonderhaar B. K. Epidermal growth factor stimulates the growth of A431 tumors in athymic mice. Cancer Lett. 1985 Sep 15;28(2):143–150. doi: 10.1016/0304-3835(85)90069-2. [DOI] [PubMed] [Google Scholar]
  8. Gullick W. J., Marsden J. J., Whittle N., Ward B., Bobrow L., Waterfield M. D. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res. 1986 Jan;46(1):285–292. [PubMed] [Google Scholar]
  9. Hirota N., Ueda M., Ozawa S., Abe O., Shimizu N. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody. Cancer Res. 1989 Dec 15;49(24 Pt 1):7106–7109. [PubMed] [Google Scholar]
  10. Hollenberg M. D. Epidermal growth factor-urogastrone, a polypeptide acquiring hormonal status. Vitam Horm. 1979;37:69–110. doi: 10.1016/s0083-6729(08)61068-7. [DOI] [PubMed] [Google Scholar]
  11. Ishikawa J., Maeda S., Sugiyama T., Nishimura R., Mizoguchi A., Kamidono S. EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene. Int J Cancer. 1989 Dec 15;44(6):1000–1004. doi: 10.1002/ijc.2910440610. [DOI] [PubMed] [Google Scholar]
  12. Kamata N., Chida K., Rikimaru K., Horikoshi M., Enomoto S., Kuroki T. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res. 1986 Apr;46(4 Pt 1):1648–1653. [PubMed] [Google Scholar]
  13. Lee K., Tanaka M., Shigeno C., Yamamoto I., Ohta S., Rikimaru K., Hatanaka M., Konishi J. Epidermal growth factor stimulates the anchorage-independent growth of human squamous cell carcinomas overexpressing its receptors. Biochem Biophys Res Commun. 1990 May 16;168(3):905–911. doi: 10.1016/0006-291x(90)91114-8. [DOI] [PubMed] [Google Scholar]
  14. Murayama Y. Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice. Ann Surg. 1990 Mar;211(3):263–268. [PMC free article] [PubMed] [Google Scholar]
  15. Ozawa S., Ueda M., Ando N., Abe O., Hirai M., Shimizu N. Stimulation by EGF of the growth of EGF receptor-hyperproducing tumor cells in athymic mice. Int J Cancer. 1987 Nov 15;40(5):706–710. doi: 10.1002/ijc.2910400523. [DOI] [PubMed] [Google Scholar]
  16. Ozawa S., Ueda M., Ando N., Abe O., Shimizu N. High incidence of EGF receptor hyperproduction in esophageal squamous-cell carcinomas. Int J Cancer. 1987 Mar 15;39(3):333–337. doi: 10.1002/ijc.2910390311. [DOI] [PubMed] [Google Scholar]
  17. Ozawa S., Ueda M., Ando N., Shimizu N., Abe O. Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas. Cancer. 1989 Jun 1;63(11):2169–2173. doi: 10.1002/1097-0142(19890601)63:11<2169::aid-cncr2820631117>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  18. Sporn M. B., Roberts A. B. Autocrine growth factors and cancer. 1985 Feb 28-Mar 6Nature. 313(6005):745–747. doi: 10.1038/313745a0. [DOI] [PubMed] [Google Scholar]
  19. Tsutsumi O., Kubota Y., Oka T. Effect of sialoadenectomy, treatment with epidermal growth factor (EGF) antiserum and replacement of EGF on the epidermis in mice. J Endocrinol. 1987 May;113(2):193–197. doi: 10.1677/joe.0.1130193. [DOI] [PubMed] [Google Scholar]
  20. Tsutsumi O., Kurachi H., Oka T. A physiological role of epidermal growth factor in male reproductive function. Science. 1986 Aug 29;233(4767):975–977. doi: 10.1126/science.3090686. [DOI] [PubMed] [Google Scholar]
  21. Tsutsumi O., Tsutsumi A., Oka T. Importance of epidermal growth factor in implantation and growth of mouse mammary tumor in female nude mice. Cancer Res. 1987 Sep 1;47(17):4651–4653. [PubMed] [Google Scholar]
  22. Ullrich A., Coussens L., Hayflick J. S., Dull T. J., Gray A., Tam A. W., Lee J., Yarden Y., Libermann T. A., Schlessinger J. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. 1984 May 31-Jun 6Nature. 309(5967):418–425. doi: 10.1038/309418a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES